EPCAM and cancer: Next, cancer cells were incubated with GZ17-6.02 to predict, whether GZ17-6.02 has any binding with CSC marker proteins like DCLK1, EPCAM, LGR5, and SOX9, but we did not find any binding of GZ17-6.02 with CSCs (Supplementary Figure 8).